High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer

Gideon Ptasznik; Nathan Papa; Brian D. Kelly; James Thompson; Phillip Stricker; Matthew J. Roberts; Michael S. Hofman; James Buteau; Declan G. Murphy; Louise Emmett; Daniel Moon

doi:10.1111/bju.15736

High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer

Gideon Ptasznik, Nathan Papa, Brian D. Kelly, James Thompson, Phillip Stricker, Matthew J. Roberts, Michael S. Hofman, James Buteau, Declan G. Murphy, Louise Emmett, Daniel Moon

Research output: Contribution to journal › Article › Other › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	5-7
Number of pages	3
Journal	BJU International
Volume	130
Issue number	S3
DOIs	https://doi.org/10.1111/bju.15736
Publication status	Published - Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bju.15736Licence: CC BY-NC-ND

Cite this

Ptasznik, G., Papa, N., Kelly, B. D., Thompson, J., Stricker, P., Roberts, M. J., Hofman, M. S., Buteau, J., Murphy, D. G., Emmett, L., & Moon, D. (2022). High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer. BJU International, 130(S3), 5-7. https://doi.org/10.1111/bju.15736

@article{0cbc33d9fb284b5f97e7933d1f9f5a6c,

title = "High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer",

author = "Gideon Ptasznik and Nathan Papa and Kelly, {Brian D.} and James Thompson and Phillip Stricker and Roberts, {Matthew J.} and Hofman, {Michael S.} and James Buteau and Murphy, {Declan G.} and Louise Emmett and Daniel Moon",

note = "Funding Information: Matthew Roberts has received grants from the RBWH Foundation, the ANZUP Trials Group Ltd and Mundipharma Pty Ltd, consulting fees from Cook Medical and travel support from the Royal Australasian College of Surgeons and Urological Society of Australia and New Zealand. He has served on the advisory boards of Peter MacCallum Cancer Centre, Melbourne and Royal Brisbane and Women's Hospital and as a board member of the . James Thompson has received payment for a lecture from Abbvie. Michael Hofman has received grants from the Prostate Cancer Foundation and payment for lectures from Janssen, Astellas, Merck/MSD, AstraZeneca and AAA/Novartis. Declan Murphy has received consulting fees from Astellas, Bayer, Janssen, Ipsen, Ferring and AstraZeneca. Louise Emmett has received funding for this article from St Vincent's Currant Foundation, St Vincent's Clinic Foundation, CINSW and SPHERE. BJUI Funding Information: Matthew Roberts is supported by a Clinician Research Fellowship from the Metro North Office of Research, Queensland Health. ",

year = "2022",

month = nov,

doi = "10.1111/bju.15736",

language = "English",

volume = "130",

pages = "5--7",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "S3",

}

Ptasznik, G, Papa, N, Kelly, BD, Thompson, J, Stricker, P, Roberts, MJ, Hofman, MS, Buteau, J, Murphy, DG, Emmett, L & Moon, D 2022, 'High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer', BJU International, vol. 130, no. S3, pp. 5-7. https://doi.org/10.1111/bju.15736

High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer. / Ptasznik, Gideon; Papa, Nathan; Kelly, Brian D. et al.
In: BJU International, Vol. 130, No. S3, 11.2022, p. 5-7.

Research output: Contribution to journal › Article › Other › peer-review

TY - JOUR

T1 - High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer

AU - Ptasznik, Gideon

AU - Papa, Nathan

AU - Kelly, Brian D.

AU - Thompson, James

AU - Stricker, Phillip

AU - Roberts, Matthew J.

AU - Hofman, Michael S.

AU - Buteau, James

AU - Murphy, Declan G.

AU - Emmett, Louise

AU - Moon, Daniel

N1 - Funding Information: Matthew Roberts has received grants from the RBWH Foundation, the ANZUP Trials Group Ltd and Mundipharma Pty Ltd, consulting fees from Cook Medical and travel support from the Royal Australasian College of Surgeons and Urological Society of Australia and New Zealand. He has served on the advisory boards of Peter MacCallum Cancer Centre, Melbourne and Royal Brisbane and Women's Hospital and as a board member of the . James Thompson has received payment for a lecture from Abbvie. Michael Hofman has received grants from the Prostate Cancer Foundation and payment for lectures from Janssen, Astellas, Merck/MSD, AstraZeneca and AAA/Novartis. Declan Murphy has received consulting fees from Astellas, Bayer, Janssen, Ipsen, Ferring and AstraZeneca. Louise Emmett has received funding for this article from St Vincent's Currant Foundation, St Vincent's Clinic Foundation, CINSW and SPHERE. BJUI Funding Information: Matthew Roberts is supported by a Clinician Research Fellowship from the Metro North Office of Research, Queensland Health.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85129069324&partnerID=8YFLogxK

U2 - 10.1111/bju.15736

DO - 10.1111/bju.15736

M3 - Article

C2 - 35362659

AN - SCOPUS:85129069324

SN - 1464-4096

VL - 130

SP - 5

EP - 7

JO - BJU International

JF - BJU International

IS - S3

ER -

High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this